Exhaled nitric oxide during exercise: Site of release and modulation by ventilation and blood flow

Charles R. Phillips, George Giraud, William E. Holden

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

To define the site of release and factors modulating exhaled nitric oxide (NO) during exercise in humans, we measured exhaled NO output during exercise, during exercise after balloon occlusion of the nasopharynx (to exclude nasal NO), and at rest with isocapneic hyperventilation or dobutamine infusion. Exhaled NO output increased from rest to exercise (57 ± 10 to 171 ± 30 nl · min-1 · m-2; p <0.003; n = 8). Exclusion of nasal NO reduced exhaled NO at rest and during exercise. Calculated nasal contribution at rest (53 ± 5%) decreased during exercise (29 ± 6%; P <0.05), whereas nonnasal contribution increased (47 ± 5 to 71 ± 6%; P <0.05). Isocapneic hyperventilation at rest increased exhaled NO output (51 ± 8 to 94 ± 22 nl · min-1 · m-2; P = 0.05). Dobutamine infusion did not increase exhaled NO output. We conclude that nasal exhaled NO decreases (and nonnasal exhaled NO increases) with exercise. We also conclude that, under the conditions of this study, increased exhaled NO output during exercise is more closely related to increased ventilation than to increased blood flow.

Original languageEnglish (US)
Pages (from-to)1865-1871
Number of pages7
JournalJournal of Applied Physiology
Volume80
Issue number6
StatePublished - Jun 1996
Externally publishedYes

Fingerprint

Ventilation
Nitric Oxide
Nose
Dobutamine
Hyperventilation
Balloon Occlusion
Nasopharynx

Keywords

  • nasal
  • nose

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Exhaled nitric oxide during exercise : Site of release and modulation by ventilation and blood flow. / Phillips, Charles R.; Giraud, George; Holden, William E.

In: Journal of Applied Physiology, Vol. 80, No. 6, 06.1996, p. 1865-1871.

Research output: Contribution to journalArticle

@article{ed3fb46c359a456ca15ce3649f8451d7,
title = "Exhaled nitric oxide during exercise: Site of release and modulation by ventilation and blood flow",
abstract = "To define the site of release and factors modulating exhaled nitric oxide (NO) during exercise in humans, we measured exhaled NO output during exercise, during exercise after balloon occlusion of the nasopharynx (to exclude nasal NO), and at rest with isocapneic hyperventilation or dobutamine infusion. Exhaled NO output increased from rest to exercise (57 ± 10 to 171 ± 30 nl · min-1 · m-2; p <0.003; n = 8). Exclusion of nasal NO reduced exhaled NO at rest and during exercise. Calculated nasal contribution at rest (53 ± 5{\%}) decreased during exercise (29 ± 6{\%}; P <0.05), whereas nonnasal contribution increased (47 ± 5 to 71 ± 6{\%}; P <0.05). Isocapneic hyperventilation at rest increased exhaled NO output (51 ± 8 to 94 ± 22 nl · min-1 · m-2; P = 0.05). Dobutamine infusion did not increase exhaled NO output. We conclude that nasal exhaled NO decreases (and nonnasal exhaled NO increases) with exercise. We also conclude that, under the conditions of this study, increased exhaled NO output during exercise is more closely related to increased ventilation than to increased blood flow.",
keywords = "nasal, nose",
author = "Phillips, {Charles R.} and George Giraud and Holden, {William E.}",
year = "1996",
month = "6",
language = "English (US)",
volume = "80",
pages = "1865--1871",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Exhaled nitric oxide during exercise

T2 - Site of release and modulation by ventilation and blood flow

AU - Phillips, Charles R.

AU - Giraud, George

AU - Holden, William E.

PY - 1996/6

Y1 - 1996/6

N2 - To define the site of release and factors modulating exhaled nitric oxide (NO) during exercise in humans, we measured exhaled NO output during exercise, during exercise after balloon occlusion of the nasopharynx (to exclude nasal NO), and at rest with isocapneic hyperventilation or dobutamine infusion. Exhaled NO output increased from rest to exercise (57 ± 10 to 171 ± 30 nl · min-1 · m-2; p <0.003; n = 8). Exclusion of nasal NO reduced exhaled NO at rest and during exercise. Calculated nasal contribution at rest (53 ± 5%) decreased during exercise (29 ± 6%; P <0.05), whereas nonnasal contribution increased (47 ± 5 to 71 ± 6%; P <0.05). Isocapneic hyperventilation at rest increased exhaled NO output (51 ± 8 to 94 ± 22 nl · min-1 · m-2; P = 0.05). Dobutamine infusion did not increase exhaled NO output. We conclude that nasal exhaled NO decreases (and nonnasal exhaled NO increases) with exercise. We also conclude that, under the conditions of this study, increased exhaled NO output during exercise is more closely related to increased ventilation than to increased blood flow.

AB - To define the site of release and factors modulating exhaled nitric oxide (NO) during exercise in humans, we measured exhaled NO output during exercise, during exercise after balloon occlusion of the nasopharynx (to exclude nasal NO), and at rest with isocapneic hyperventilation or dobutamine infusion. Exhaled NO output increased from rest to exercise (57 ± 10 to 171 ± 30 nl · min-1 · m-2; p <0.003; n = 8). Exclusion of nasal NO reduced exhaled NO at rest and during exercise. Calculated nasal contribution at rest (53 ± 5%) decreased during exercise (29 ± 6%; P <0.05), whereas nonnasal contribution increased (47 ± 5 to 71 ± 6%; P <0.05). Isocapneic hyperventilation at rest increased exhaled NO output (51 ± 8 to 94 ± 22 nl · min-1 · m-2; P = 0.05). Dobutamine infusion did not increase exhaled NO output. We conclude that nasal exhaled NO decreases (and nonnasal exhaled NO increases) with exercise. We also conclude that, under the conditions of this study, increased exhaled NO output during exercise is more closely related to increased ventilation than to increased blood flow.

KW - nasal

KW - nose

UR - http://www.scopus.com/inward/record.url?scp=0030054692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030054692&partnerID=8YFLogxK

M3 - Article

C2 - 8806888

AN - SCOPUS:0030054692

VL - 80

SP - 1865

EP - 1871

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 6

ER -